Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 25,701–25,720 of 25,720 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00188370	Ultrasound Biomicroscopy - Apoptosis	completed	Phase 2	50	University Health Network, TorontoOTHER	1	Sep 16, 2005	clinicaltrials
NCT00172640	Genetic Studies in Liver Cancer Patients	unknown	—	40	National Taiwan University HospitalOTHER	1	Sep 15, 2005	clinicaltrials
NCT00154986